Objective: To evaluate whether oxytocin titration for postdates labor induction differs among women who are normal weight, overweight, and obese and whether length of labor and birth method differ by oxytocin titration and body mass index (BMI).
Women who are obese are more likely to experience poor labor outcomes such as longer length of labor (LOL) and cesarean birth (Hilliard, Chauhan, Zhao, & Rankins, 2012; Norman et al., 2012; Poobalan, Aucott, Gurung, Smith, & Bhattacharya, 2009 ). The average length of the first stage of labor for women who are obese is 0.6 to 2.89 hours longer than for women who are normal weight (Hilliard et al., 2012; Kominiarek et al., 2011; Norman et al., 2012) . Longer LOL can be associated with greater incidence of postpartum hemorrhage, and women who are obese are 1.5 to 2 times more likely to experience postpartum hemorrhage than women who are normal weight (Bhattacharya et al., 2007; Zhang, Bricker, Wray, & Quenby, 2007) . Women who are obese are 3.5 times more likely to have cesarean birth during the first stage of labor (Zhang et al., 2007) and are at 1.5 to 5 times the risk for unplanned cesarean birth than women who are normal weight (Garabedian, Williams, Pearce, Lain, & Hansen, 2011; Pevzner, Powers, Rayburn, Rumney, & Wing, 2009; Poobalan et al., 2009 ).
Intravenous oxytocin, the medication most commonly used for IOL, is a high-alert medication (Institute for Safe Medication Practices, 2014). Risks related to oxytocin infusion include tachysystole (more than five uterine contractions in 10 minutes averaged over 30 minutes), fetal heart rate (FHR) category changes, and neonatal acidemia at birth (Heuser et al., 2013; Jonsson, Norden-Lindeberg, Ostlund, & Hanson, 2008; Kunz, Loftus, & Nichols, 2013; Macones, Hankins, Spong, Hauth, & Moore, 2008; Simpson & James, 2008) . Safe and effective oxytocin titration is based on FHR and uterine contraction (UC) tracings (American College of Obstetricians and Gynecologists, 2009), commonly obtained using external monitors. However, the use of external monitors to obtain accurate FHR and UC tracings becomes less effective with increasing body mass index (BMI; James & Maher, 2009; Ray, Hildreth, & Esen, 2008) . Despite the risks and prevalent use of oxytocin, little is known about the association between oxytocin titration and maternal outcomes across BMI groups.
Current practice regarding oxytocin administration is based on pharmacokinetic studies from two to three decades ago, when investigators did not report BMI (Leake, Weitzman, & Fisher, 1980; Perry et al., 1996; Seitchik, Amico, Robinson, & Castillo, 1984) . More recently, researchers evaluated oxytocin requirements across BMI groups and found that oxytocin dosage increases with increasing BMI (Hill, Reed, & Cohen, 2015; Pevzner et al., 2009; Roloff, Peng, SanchezRamos, & Valenzuela, 2015; Soni, Chivan, & Cohen, 2013) . Authors of these studies reported overall trends in oxytocin administration, but it remains unknown whether nurses administer oxytocin differently across BMI groups. Additionally, these authors described the use of FHR and UC monitoring in their protocol, but these nursing interventions were not included in their analyses. The current obesity epidemic, the widespread use of oxytocin, and barriers to effective monitoring related to obesity pose a serious risk to women who are obese and to their infants. Studies are needed to comprehensively examine oxytocin titration practices, interventions related to oxytocin titration, and labor outcomes across BMI groups.
The first aim of our study was to determine whether titration of intravenous oxytocin infusion for postdates IOL differed among normal weight, overweight, and obese women, controlling for maternal characteristics, labor interventions, and provider type. The second aim was to determine whether labor outcomes (LOL, and method of birth) for women who underwent postdates IOL differed by (a) titration of oxytocin infusion, controlling for the previously stated variables, and (b) titration of oxytocin infusion by BMI group, controlling for the previously stated variables.
Methods

Setting and Sample
This retrospective cohort study included women who gave birth after IOL between January 1, 2013 and June 30, 2013 at a large Midwestern U.S., university-affiliated medical center. Obstetriciangynecologists and certified nurse-midwives (CNMs) have privileges to practice, and obstetric medical residents manage the labor care of their clinic patients in conjunction with attending obstetrician-gynecologists. The policy at the study site dictates that the infusion be set to titrate at 1 to 2 milliunits/minute by infusion pump and may be increased every 15 to 30 minutes at the discretion of the nurse or obstetric provider. The rate must be decreased if signs of fetal intolerance (e.g., fetal heart rate decelerations) or tachysystole are noted.
Inclusion criteria for the study included the following: all women who were admitted for postdates IOL (defined as IOL at 41 weeks gestation or greater with no listed medical indication or 40 weeks gestation or greater with provider notation of postdates IOL), received intravenous oxytocin, had singleton pregnancy in the vertex position, and had documented weight and height at initiation of prenatal care and at labor admission. Exclusion criteria were scheduled, previous, or indicated cesarean; maternal or fetal indication for IOL; fetal demise; known lethal fetal anomalies; and women who were underweight at labor admission (BMI < 18.5 kg/m 2 ).
Using electronic medical records, a dataset containing study variables for all women who were admitted at 40 weeks gestational age or greater and who received intravenous oxytocin was obtained. The first author reviewed all electronic records to verify that women were admitted for postdates IOL. Any chart in which it was indicated that a woman was admitted for spontaneous labor, spontaneous rupture of membranes, or IOL for any maternal or neonatal condition was excluded. The institutional review boards at Northwestern University (data collection site), and the University of Illinois at Chicago (data analysis site) approved this study.
Measures
For women who met study criteria, data were extracted from electronic medical records on primary variables of oxytocin administration, BMI, LOL, and method of birth and secondary variables of participants' characteristics, provider type, and labor interventions (see Tables 1 and 2) . We divided the sample into three BMI groups (normal weight ¼ BMI < 25.00, overweight ¼ BMI 25.00 to 29.99, and obese ¼ BMI $ 30.00) according to the World Health Organization BMI categories and used BMI at labor admission because this is consistent with other investigators who have analyzed oxytocin administration and BMI (Hill et al., 2015; Norman et al., 2012; Pevzner et al., 2009; Roloff et al., 2015; Soni et al., 2013; World Health Organization, 2006) . Length of labor was defined as the time from the first intervention to induce labor (cervical ripening, oxytocin infusion, or artificial rupture of membranes [AROM]) until birth. Method of birth was vaginal or cesarean, and cesarean indication was for arrest of dilation/fetal descent or for change in FHR category. Oxytocin administration variables were defined as follows: total oxytocin dose, total amount in units infused from initiation until discontinuation or birth; length of infusion, the time from initiation until discontinuation or birth; maximum oxytocin rate, the maximum infusion rate in milliunits/minute reached during labor; units/hour of infusion, total oxytocin dose divided by length of infusion; time (minutes) from initiation to the maximum rate, time (minutes) between rate changes from initiation to maximum rate, and time (minutes) between rate changes from initiation to the final oxytocin titration.
Participants' characteristics extracted from the medical record included age (in years), BMI at Although Bishop score is not documented at the study site, house staff (obstetric resident or staff CNM) review the orders placed by a woman's attending provider; evaluate cervical dilation, effacement, and fetal station upon admission; and determine whether cervical ripening is warranted. The induction and augmentation policy at this institution prohibits oxytocin from being used in conjunction with cervical ripening medications, but low-dose oxytocin may be administered while the cervical ripening balloon is in place at the provider's discretion. Obstetric providers discontinue cervical ripening when the cervix is dilated approximately 3 to 4 centimeters, and the oxytocin infusion is initiated or increased per protocol. Cervical ripening methods included cervical ripening balloon (with or without low-dose oxytocin), misoprostol, and dinoprostone.
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Analysis
Data analysis was conducted with the use of SPSS, version 22.0. To describe the sample, we used the c 2 test to examine differences in categoric variables such as maternal characteristics, provider type, and other interventions (e.g., epidural use, cervical ripening) across BMI groups. Because some cell sizes contained fewer than five cases, Fisher's exact test was done for all categorical variables. We used analysis of variance to test for differences in continuous variables (e.g., maternal age, cervical dilation upon admission) across the three BMI groups.
Analysis of variance (ANOVA) and analysis of covariance (ANCOVA) were used to test Study Aim 1. First, ANOVA was used to evaluate relationships between oxytocin administration variables and BMI. Then, ANCOVA was used to evaluate relationships between oxytocin administration variables across the three BMI groups, controlling for potential confounding variables.
Multiple linear and logistic regression models were used to evaluate relationships between oxytocin dosing variables and outcome variables (LOL and method of birth), controlling for BMI and potential confounding variables to test Study Aim 2. The multiple linear regression (for LOL) and the multiple logistic regression (for method of birth) models regressed the oxytocin administration variables, BMI, and all covariates on the labor outcome. Participants' characteristics that had statistically significant (p # .05) bivariate associations with BMI groups and those with clinical significance were considered potential confounding variables and were controlled for in the analysis. Multicollinearity checks were done, and variables that were redundant were removed from the model. Assumption checks were conducted for dependent variables. Data distributions were approximately normal for multiple linear regression and for ANOVA and ANCOVA. See Supplemental Figures S1, S2, S3, S4, S5, S6, and S7 for Q-Q plots, skewness reports, and results of nonparametric testing that show that oxytocin administration variables were approximately normally distributed.
Power analyses for ANOVA and ANCOVA were completed before data collection based on oxytocin variables (Study Aim 1). Power analyses for multiple regression were based on LOL and method of birth (Study Aim 2) across BMI groups. We based our sample size on the power analysis that required the largest sample. With a sample size of n ¼ 270, we calculated 80% power to detect a moderate effect size (f) of .25 (p ¼ .05). G*Power software version 3.1 was used for power analysis.
Results
Demographics
Total sample. Among the 570 women who were admitted at 40 weeks gestational age or greater, gave birth between January 1, 2013 and June 30, 2013, and received oxytocin, 280 met inclusion criteria (see Figure 1) Differences across BMI groups. Significant differences across BMI groups were found related to characteristics of participants, provider type, use of cervical ripening, and method of birth (see Tables 1 and 2) . One-way, three-group ANOVAs with post hoc testing showed significant betweengroup differences for gestational weight gain, dilation upon admission, and newborn birth weight. Table 2 ). Significant relationships among variables were the same for c 2 and Fisher's exact tests. A greater percentage of non-Hispanic Black and Hispanic participants were obese compared with normal weight. More participants who were obese had public insurance and an obstetric resident for birth than participants who were overweight or normal weight.
More participants who were obese had a CNM for birth than participants who were overweight. These differences across BMI groups were controlled for in the ANCOVA and regression analyses.
Significant differences in labor outcomes across BMI groups were detected for LOL and method of birth (see Tables 1 and 2 Figure 2) : participants who were normal weight had a cesarean birth rate of 4.8% compared with 33.6% and 42.4% for participants who were overweight and obese, respectively (p ¼ .001).
Oxytocin Administration Across BMI Groups
In Study Aim 1, we analyzed oxytocin administration across BMI groups controlling for maternal age at birth, gestational weight gain, newborn birth weight, gestational age, race/ethnicity, insurance type, provider type, cervical ripening, comorbidities, parity, rupture of membrane method, and epidural use (see Table 3 ). In the unadjusted model (ANOVA), there were no overall mean differences across BMI groups for the main effects of total oxytocin dose, length of infusion, maximum oxytocin rate, units/hour of infusion, time from initiation to the maximum rate, time (in minutes) between rate changes from initiation to the maximum rate, and time (in minutes) between rate changes from initiation to the last rate change. However, post hoc testing of ANOVA showed significant differences for two oxytocin administration variables. Participants who were obese received more total oxytocin (M ¼ 
Relationships Among BMI, Oxytocin Administration, and Labor Outcomes
In Study Aim 2, we analyzed relationships among oxytocin variables and labor outcomes (LOL and method of birth) by BMI group, controlling for maternal age at birth, gestational weight gain, newborn birth weight, gestational age, race/ ethnicity, insurance type, provider type, cervical ripening, comorbidities, parity, rupture of membrane method, epidural use, monitoring type, cesarean indication, and oxytocin administration variables. For participants who had vaginal births, in a multiple linear regression model that included oxytocin administration variables and all covariates (see Table 4 ), significant predictors of longer LOL were other non-Hispanic race/ ethnicity, use of cervical ripening, longer length of infusion, fewer minutes between rate changes from initiation to maximum rate, increased maximum oxytocin rate, and fewer units/hour of infusion.
For participants who had cesarean births, in a multiple linear regression model that included oxytocin administration variables and all covariates (see Table 5 ), significant predictors of longer LOL were public insurance, Asian nonHispanic race/ethnicity, Black non-Hispanic race/ethnicity, use of cervical ripening, cesarean indication for arrest, longer length of infusion, and fewer minutes between rate changes from initiation to last rate change. Resident provider type, AROM, and IUPC use were significant predictors for shorter LOL before cesarean birth.
For method of birth (vaginal or cesarean), in a multiple logistic regression model that included oxytocin administration variables and all covariates (see Table 6 ), overweight and obese BMI groups, greater newborn birth weight, nulliparity, absence of an anxiety/depression diagnosis, fewer units/hour of infusion, IUPC monitoring, and use of cervical ripening were significant predictors for cesarean birth. Additionally, we repeated all analyses using BMI at first prenatal visit and found that significant relationships did not change.
Discussion
In this study of women induced for postdates pregnancy, participants who were obese received more oxytocin than participants who were nonobese, although significant differences did not hold when controlling for potential confounders. There was an overall effect for LOL to increase with BMI group, but no between-group differences were detected. Participants who were obese or overweight had greater cesarean birth rates than participants who were normal weight. Maeder, A. B. et al.
We found that time between oxytocin rate changes to reach the maximum dose was significantly longer for the overweight group than for the obese group in the unadjusted ANOVA. The reason for this difference is unclear. Additionally, we found in the unadjusted ANOVA that participants who were obese received more total oxytocin than participants who were overweight. This is to be expected, because women who are obese tend to have longer LOL than women who are non-obese. However, units/hour of infusion did not differ among BMI groups. Intravenous oxytocin is absorbed into the extracellular fluid space (Arias, 2000) , and women who are obese have a larger Oxytocin Infusion for Postdates Labor Induction extracellular fluid space than women who are nonobese (Mager, 2009 ). Because of this physiologic difference, women who are obese may need a larger dose of oxytocin to promote effective labor and vaginal birth than women who are non-obese. Additionally, researchers have found links between decreased uterine contractility and endocrine factors such as leptin, ghrelin, visfatin, and apelin, which are often found at different blood levels in persons who are obese and of normal weight (AlSaif, Mumtaz, & Wray, 2015; Hehir, Glavey, & Morrison, 2008; Hehir & Morrison, 2012; Moynihan, Hehir, Glavey, Smith, & Morrison, 2006) . Another proposed physiologic mechanism to explain variations in oxytocin requirements across BMI groups is differences in oxytocin receptor gene expression. However, one group of authors found no difference in oxytocin receptor gene expression among women who were obese versus non-obese (Grotegut, Gunatilake, Feng, Heine, & Murtha, 2013) . One additional explanation for variation in oxytocin requirements across BMI groups may be differences in endogenous oxytocin. Animal studies have shown that oxytocin deficiency is related to increased food intake and weight gain (Yamashita et al., 2013) . If women who are obese also have oxytocin deficiency, this could explain why they are at risk for longer LOL and greater cesarean rate.
Our finding that total oxytocin dose during labor did not differ across BMI groups in the ANCOVA was not consistent with other studies, in which researchers showed increasing oxytocin use for greater BMI groups when controlling for potential confounders (Pevzner et al., 2009) . One explanation for the absence of this association in our study might be related to the smaller number of participants in the normal weight group. Additionally, the true relationship between BMI and oxytocin administration may not be linear and, therefore, be too complicated for ANCOVA. Pevzner et al. (2009) found that median oxytocin dose and duration of infusion were significantly greater for women who were obese (BMI ¼ 30-39.9 kg/m 2 ) and extremely obese (BMI $ 40.0 kg/ m 2 ) rather than lean (BMI # 29.9 kg/m 2 ) when controlling for confounders. Our greatest BMI group included all participants with BMI of 30.0 kg/m 2 or greater, and because we did not divide the obese group by obesity classes I, II, and III (World Health Organization, 2006), we did not find the statistical differences in our adjusted analysis that Pevzner and colleagues did. Thus, there may be a threshold point for BMI at which a significant relationship between BMI and oxytocin is more important than other predictors.
We found differences in predictors of LOL for participants who had vaginal compared with cesarean birth. Longer length of infusion was associated with longer LOL for participants who had vaginal and cesarean births. Greater maximum oxytocin rate was associated with longer LOL only for participants who gave birth vaginally. It is likely that oxytocin dose was increased for participants who were making even slow labor progress who then achieved vaginal birth.
A novel finding is that BMI was not a predictor of LOL in our study. This finding is inconsistent with previous research in which authors showed that increased BMI is related to longer LOL (Hilliard et al., 2012; Norman et al., 2012) . We found that oxytocin administration variables, in particular units/hour of infusion, were predictive of LOL, which suggests that oxytocin administration practices may be more important than maternal BMI for prediction of LOL. Fewer units/ hour of infusion was associated with longer LOL for participants who had vaginal births, regardless of BMI. This variable was included in the model because women who are obese often have longer LOLs than women who are normal weight, and we wanted to consider the amount of oxytocin women receive relative to their LOL. Hill and colleagues (2015) analyzed a similar variable (amount of oxytocin given per minute of first stage labor) in a sample of women who were obese or non-obese, all of whom gave birth vaginally. In their sample, women who were obese received significantly more oxytocin per minute of first stage labor than women who were lean (Hill et al., 2015) . This finding indicates that women who are obese require more oxytocin than women who are not obese to achieve vaginal birth. Because participants who were obese in our sample tended to have longer LOL, units of oxytocin given per hour of infusion may be especially important to consider for this group.
Use of cervical ripening was associated with longer LOL for all participants. This is consistent with previous studies in which researchers
Women who were obese received more total oxytocin in labor, but they may not have received adequate units of oxytocin per hours of infusion.
showed that cervical ripening is used to facilitate labor (Tam, Conte, Schuler, Malang, & Roque, 2013 Gynecologists, 2003) . If UC strength is deemed to be adequately strong by IUPC, and cervical dilation does not progress, providers may decide to perform a cesarean birth rather than continue to wait, thus shortening LOL.
Maternal and provider characteristics that were significant predictors of LOL included race/ ethnicity, provider type, and insurance type. Asian non-Hispanic and Black non-Hispanic participants had longer LOLs than White nonHispanic participants among those who had cesarean births. Getahun et al. (2009) found that Black and Asian women had greater rates of labor dystocia and primary cesarean rate than White women. Reasons for these racial/ethnic differences might include greater rates of comorbidities, such as gestational diabetes with subsequent macrosomia (Yuen & Wong, 2015) or hypertension (Martin et al., 2011) , that may contribute to impaired uterine blood flow, lowered uterine oxygenation, and decreased contractility (Quenby, Pierce, Brigham, & Wray, 2004) . However, comorbidities were not significant predictors of LOL in our analyses. Participants who had an obstetric medical resident instead of an obstetrician-gynecologist or CNM during labor had shorter LOLs before cesarean birth. This could indicate cesarean birth for change in FHR category rather than for labor arrest. Although not statistically significant, there was a trend in our sample for more participants cared for by residents to have cesarean births for change in FHR category (50.0%) than for participants cared for by CNMs (14.3%) or obstetrician-gynecologists (20.9%). Public insurance type was associated with longer LOL for participants who had cesarean birth. All participants cared for by residents were enrolled in public insurance, and obstetrician-gynecologists and CNMs cared for a mix of publicly and privately insured participants. Although we controlled for type of insurance in the analysis, there might be a risk factor related to low socioeconomic status that is not captured by insurance type or some other unmeasured variable related to provider type.
Participants who were overweight or obese were more likely to have a cesarean birth than participants who were normal weight. Additionally, greater newborn weight was associated with cesarean birth. Women who are overweight or obese or who have excessive gestational weight gain are at risk to have large-for-gestational-age or macrosomic newborns (Ay et al., 2009; Kim, Sharma, Sappenfield, Wilson, & Salihu, 2014; Yu et al., 2013) . Fewer units/hour of infusion was associated with cesarean birth. This may be related to underdosing of the oxytocin infusion to promote effective labor and vaginal birth or lower infusion rates due to signs of fetal distress. Use of an IUPC was also a significant predictor for cesarean birth. Increased incidence of cesarean birth with internal monitor use has been reported (Harper, Shanks, Tuuli, Roehl, & Cahill, 2013) . It is not known whether use of internal monitors places women at risk for cesarean birth or if internal monitors are more often used for women who show signs of labor dystocia and/or fetal distress.
Effective use of external monitors becomes more difficult as BMI increases (Ray et al., 2008) . In our sample, we expected more participants who were obese to have internal monitoring than participants who were overweight or normal weight. However, there were no significant differences across BMI groups for monitoring type. Although routine use of internal monitoring is not recommended because of reports of increased risk for infection (Harper et al., 2013) , perhaps if internal monitoring were used for women who are obese when external monitoring is inadequate, the oxytocin infusion could be titrated more effectively to promote an adequate UC pattern. This might shorten the total LOL and increase vaginal birth rates for women who are obese. Additionally, electrohysterography may be a valuable tool to monitor UCs in women who are obese when external tocodynamometry monitoring is ineffective and providers wish to avoid invasive monitoring. Electrohysterography has been found to be a more accurate UC monitoring method than tocodynamometry even for women who are obese (Euliano et al., 2013) . Because nursing interventions, including electronic fetal and UC monitoring, are more challenging and time consuming when caring for women who are obese, hospital administrators who plan nurse staffing should consider that these women may
Oxytocin Infusion for Postdates Labor Induction require one-to-one nursing for the nurse to provide exceptional care (Cesario, 2003) .
Limitations
Our study had limitations. First, we had a relatively small normal weight group compared with the overweight and obese groups. This difference might have contributed to an inability to detect statistical differences in oxytocin variables when covariates were added to the ANOVA model. In addition, with a larger normal weight sample we might not have had wide confidence intervals and odds ratios that overestimated the risk of cesarean birth for overweight and obese women. We expected more women to meet our inclusion criteria given that there are more than 12,000 births per year at the study site, and national data indicate that approximately 14.6% of these women would meet our main study criteria: singleton birth at 41 weeks gestation or beyond . This would have yielded 876 women who had the potential to meet all of our study inclusion criteria, which would have given us more equal sample sizes across BMI groups. We also examined the sample when dividing it into two BMI groups (non-obese and obese). We combined participants who were normal weight and overweight to create a non-obese group similar to Pevzner et al. (2009) , and then we compared this non-obese group with the obese group for birth outcomes and oxytocin administration variables. The difference between the non-obese and obese groups was larger than the difference between the obese and overweight groups, indicating that the normal weight participants in the non-obese group magnified this difference. The division of participants into three BMI groups yielded better estimates of the relationships seen in the sample.
Second, we used a retrospective design, and there may be related biases. Third, the use of BMI at labor admission might be biased because it takes into account gestational weight gain, but other investigators also used BMI during this timeframe (Norman et al., 2012; Pevzner et al., 2009; Soni et al., 2013) . A pregnancy-specific BMI measure may be more helpful when studying pregnant women. Fourth, because race/ ethnicity was self-reported on admission documents, data were missing for race/ethnicity, resulting in 13.2% of participants categorized as "other non-Hispanic." These participants might have been of mixed race and did not identify with any individual race category. Findings might have differed if their race/ethnicity was known. Finally, we used oxytocin dosages rather than directly measuring oxytocin in the cerebral spinal fluid or serum. Differences across BMI groups might be found when using these direct measures of oxytocin. It is known that intravenous oxytocin is absorbed into the extracellular fluid space (Arias, 2000) and that obese women have a larger extracellular fluid space than normal weight women (Mager, 2009) . Because of this physiologic difference, obese women may actually need a larger dose of oxytocin to promote effective labor and vaginal birth.
Conclusion
In conclusion, our study showed that participants who were obese and experienced postdates IOL received more oxytocin than participants who were of normal weight. Additionally, fewer units/ hour of infusion was associated with cesarean birth and with longer LOL for participants who had vaginal birth. Because more participants who were obese had cesarean birth, they may have received inadequate units of oxytocin per hours of infusion. A challenge for providers is to safely deliver this high-alert medication for women who are obese when commonly used external monitoring methods fail to produce an accurate FHR and UC pattern. Our findings support consideration of women who are obese to be at greater risk for labor dystocia and cesarean birth. For these women, alternate UC monitoring methods to tocodynamometry may need to be considered. Current BMI groups may not be the best measure when evaluating pregnant women, and future research should focus on the women at greatest risk for poor pregnancy outcomes, specifically subcategories of the obese group: Class I, Class II, and Class III (World Health Organization, 2006) .
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Commonly used external fetal heart rate and uterine contraction monitors may be inadequate in the administration of intravenous oxytocin for women who are obese.
